Oje Imoukhuede

Red Deer, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment.

Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: June 26, 2025

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.

Journal: Lancet (London, England)

Published: April 18, 2024

Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.

Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.

Journal: Stroke

Published: January 26, 2024

Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase.

Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase.

Journal: Stroke

Published: January 04, 2024

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.

Journal: Lancet (London, England)

Published: May 23, 2022

Shattering the Carotids.

Shattering the Carotids.

Journal: Stroke

Published: March 26, 2021

Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.

Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: December 06, 2018

Etiologic classification of TIA and minor stroke by A-S-C-O and causative classification system as compared to TOAST reduces the proportion of patients categorized as cause undetermined.

Etiologic classification of TIA and minor stroke by A-S-C-O and causative classification system as compared to TOAST reduces the proportion of patients categorized as cause undetermined.

Journal: Cerebrovascular diseases (Basel, Switzerland)

Published: February 17, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026